Comments
Loading...
VYNE Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VYNE | Benzinga
VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS
$-0.200
Quarterly Revenue
$202.00K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$605.00K
Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics | -$0.22 | — | — | — | $198.00K | — | — | — | 08/13/2025 | Get Alert |
| VYNE | VYNE Therapeutics | -$0.15 | -$0.29 | -$0.20 | 31.03% | $98.00K | $50.00K | $202.00K | 304.00% | 05/08/2025 | Get Alert |
| VYNE | VYNE Therapeutics | -$0.18 | -$0.31 | -$0.28 | 9.68% | $76.00K | $180.00K | $84.00K | -53.33% | 03/06/2025 | Get Alert |
| VYNE | VYNE Therapeutics | -$1.75 | -$0.23 | -$0.29 | -26.09% | $114.00K | $110.00K | $121.00K | 10.00% | 11/07/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.82 | -$0.19 | -$0.22 | -15.79% | $135.00K | $110.00K | $198.00K | 80.00% | 08/14/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$1.48 | -$0.24 | -$0.15 | 37.50% | $99.00K | $100.00K | $98.00K | -2.00% | 05/09/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.97 | -$0.50 | -$0.18 | 64.00% | $6.00K | $150.00K | $76.00K | -49.33% | 02/29/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.52 | -$1.97 | -$1.75 | 11.17% | $167.00K | — | $114.00K | — | 11/13/2023 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.34 | -$1.99 | -$2.82 | -41.71% | $126.00K | $100.00K | $135.00K | 35.00% | 08/14/2023 | Get Alert |
| VYNE | VYNE Therapeutics | $1.80 | -$2.61 | -$1.48 | 43.30% | $178.00K | — | $99.00K | — | 05/11/2023 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.60 | -$3.24 | -$2.97 | 8.33% | $2.29M | $60.00K | $6.00K | -90.00% | 03/09/2023 | Get Alert |
| VYNE | VYNE Therapeutics | -$7.38 | -$3.06 | -$2.52 | 17.65% | $4.09M | $130.00K | $167.00K | 28.46% | 11/10/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$6.30 | -$3.06 | -$2.34 | 23.53% | $4.26M | $100.00K | $126.00K | 26.00% | 08/12/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.96 | -$2.88 | $1.80 | 162.50% | $230.00K | $370.00K | $178.00K | -51.89% | 05/12/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$7.74 | -$4.32 | -$3.60 | 16.67% | $4.29M | $4.12M | $2.29M | -44.37% | 03/17/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$9.36 | -$5.76 | -$6.48 | -12.50% | $3.27M | $4.76M | $4.09M | -14.16% | 11/10/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.28 | -$6.30 | -$6.30 | 0.00% | $11.69M | $6.21M | $4.26M | -31.43% | 08/12/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.80 | -$7.38 | -$6.66 | 9.76% | — | $5.31M | $4.12M | -22.43% | 05/06/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.56 | -$9.54 | -$7.74 | 18.87% | — | $4.71M | $4.29M | -9.00% | 03/04/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.80 | -$12.24 | -$9.36 | 23.53% | — | $3.25M | $3.27M | 0.58% | 11/05/2020 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.76 | -$1.00 | -$3.28 | -228.00% | — | $2.42M | $11.69M | 382.98% | 08/06/2020 | Get Alert |
VYNE Therapeutics (VYNE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $-0.20 | $-0.29 | 31.0 % |
| Q4 | 2025-03-06 | $-0.28 | $-0.31 | 9.68 % |
| Q3 | 2024-11-07 | $-0.29 | $-0.23 | -26.1 % |
| Q2 | 2024-08-14 | $-0.22 | $-0.19 | -15.8 % |
VYNE Therapeutics (VYNE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $202.00K | $50.00K | 304.0 % |
| Q4 | 2025-03-06 | $84.00K | $180.00K | -53.3 % |
| Q3 | 2024-11-07 | $121.00K | $110.00K | 10.0 % |
| Q2 | 2024-08-14 | $198.00K | $110.00K | 80.0 % |
FAQ
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics (VYNE) is scheduled to report earnings on August 13, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for VYNE Therapeutics (NASDAQ:VYNE)?
The Actual EPS was $-0.20, which beat the estimate of $-0.29.
What were VYNE Therapeutics’s (NASDAQ:VYNE) revenues?
The Actual Revenue was $202K, which beat the estimate of $50K.
Browse earnings estimates, EPS, and revenue on all stocks.
